stockrowRepligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024.
- Revenue
- +10.9%
- EPS
- −351.9%
- Free cash flow
- −11.5%
- Total debt
- +3.28%
Quarter to September 2026, against a year earlier
Follow RGEN
Alert me
Repligen Corporation (RGEN) Total debt
Repligen Corporation's total debt at the end of fiscal 2025 was $542.2M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $555.6M. Over the past ten years it has ranged from $95.3M (fiscal 2016) to $579.6M (fiscal 2023); the current reading is higher than 90% of that period. Repligen Corporation ranks 15th of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $542.2M | 3.17% |
| FY2024 | $525.6M | (9.32%) |
| FY2023 | $579.6M | 39.45% |
| FY2022 | $415.6M | 16.33% |
| FY2021 | $357.3M | 32.45% |
| FY2020 | $269.7M | 13.93% |
| FY2019 | $236.8M | 128.79% |
| FY2018 | $103.5M | 4.27% |
| FY2017 | $99.3M | 4.18% |
| FY2016 | $95.3M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $555.6M | 0.83% |
| Jun 2026 | $551.0M | 0.82% |
| Mar 2026 | $546.6M | 0.81% |
| Dec 2025 | $542.2M | 0.80% |
| 38 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| BAX Baxter International Inc. compare | $8.6B |
| BLCO Bausch + Lomb Corporation compare | $5.1B |
| AVTR Avantor, Inc. compare | $3.7B |
| TFX Teleflex Incorporated compare | $2.8B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| ATR AptarGroup, Inc. compare | $1.4B |
| RGEN Repligen Corporation | $555.6M |
| SOLV Solventum Corporation compare | $507.0M |
| ALGN Align Technology, Inc. compare | $127.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on RGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement